Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Breaking barriers in ovarian stimulation: from theory to practice

Precongress Course 14

MEFS MEFS Exchange course

 

Course coordinators
Johnny Awwad (Sidra Medicine - Qatar) and Mohammad Aboulghar (Egyptian IVF-ET Center, Egypt)

Course type
Advanced

Course description
This comprehensive course provides an in-depth exploration of ovarian stimulation strategies in the context of in vitro fertilisation (IVF). It offers cutting-edge insights into the latest protocols, innovations, and challenges in ovarian stimulation. Key topics include pretreatment strategies, hormonal monitoring, and alternative suppression protocols, as well as specialised approaches for unique patient populations. Participants will also explore cost-effectiveness, patient safety, and the integration of innovative protocols into clinical practice. Through interactive lectures and expert-led sessions, attendees will gain practical knowledge to refine their clinical decision-making and optimise patient outcomes in IVF.

Target audience
REI physicians, urologists, embryologists, nurses, business partners, and legal professionals

Educational needs and expected outcomes
As the field of reproductive medicine continues to evolve, healthcare professionals need to stay updated on the latest advancements and evidence-based practices in ovarian stimulation for IVF.

Key educational needs include:

  • Understanding the variety of ovarian stimulation protocols and when to apply them for different patient profiles.
  • Gaining clarity on the hormonal monitoring required during ovarian stimulation and how to interpret key metrics to optimise outcomes.
  • Exploring innovative pretreatment strategies and their role in enhancing IVF success rates.
  • Identifying cost-effective approaches to treatment while maintaining high standards of care.
  • Gaining knowledge on specialised stimulation techniques for cancer patients and other unique populations requiring fertility preservation.
  • Familiarity with alternative pituitary suppression protocols and their clinical implications.
  • Staying informed on the latest developments in GnRH agonist triggering and luteal phase supplementation.

Upon completion of this course, participants will be able to:

  1. Design tailored ovarian stimulation protocols based on individual patient characteristics, including those undergoing fertility preservation and other high-risk treatments.
  2. Interpret and apply hormonal monitoring data to make informed adjustments during ovarian stimulation cycles, enhancing patient outcomes.
  3. Incorporate new pretreatment strategies and alternative protocols into practice, improving IVF success rates while minimising risks.
  4. Evaluate the cost-effectiveness of oral stimulation agents and other treatment approaches, balancing financial considerations with clinical benefits.
  5. Apply the latest evidence on GnRH agonist triggering to optimise timing and patient care.
  6. Utilise tailored treatment protocols for cancer patients undergoing egg cryopreservation, ensuring safety and efficacy.

This course will equip attendees with the knowledge and skills necessary to refine their clinical practice and advance IVF care for diverse patient populations.

Programme 



Sunday 29 June 2025

Chairs
Chairperson to be announced
Chairperson to be announced
09:00 - 09:30
IVF pretreatment strategies: unlocking their uses and benefits strategies
Mohamed Aboulghar, Egypt
09:30 - 09:45
Discussion
09:45 - 10:15
LH supplementation: timing it right for optimal results
Yacoub Khalaf, United Kingdom
10:15 - 10:30
Discussion
10:30 - 11:00
Coffee break
Chairperson to be announced
Chairperson to be announced
11:00 - 11:30
Hormonal monitoring in IVF: key metrics and their impact
Ying C. Cheong, United Kingdom
11:30 - 11:45
Discussion
11:45 - 12:15
Random start protocols: expanding opportunities in IVF
Juan A. Garcia-Velasco, Spain
12:15 - 12:30
Discussion
12:30 - 13:30
Lunch break
Chairperson to be announced
Chairperson to be announced
13:30 - 14:00
Oral stimulation agents in IVF: a cost-effective approach?
Johnny Awwad, Qatar
14:00 - 14:15
Discussion
14:15 - 14:45
Rethinking pituitary suppression: progestin-primed and beyond
Nikolaos P. Polyzos, Spain
14:45 - 15:00
Discussion
15:00 - 15:30
Coffee break
Chairperson to be announced
Chairperson to be announced
15:30 - 16:00
GnRH agonist triggering: the latest innovations
George Lainas, Greece
16:00 - 16:15
Discussion
16:15 - 16:45
Egg cryopreservation for cancer patients: safe and effective stimulation strategies
Kirsten Louise Tryde Macklon, Denmark
16:45 - 17:00
Discussion